The efficacy and safety of ivabradine hydrochloride in hemodialysis patients with chronic heart failure.

Sayuri KawasakiYukinao SakaiShinsuke HarasawaAkihito InatsuYoshiaki KubotaAkio HiramaTetsuya KashiwagiMasato Iwabu

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2024)

Ivabradine hydrochloride improved dialysis-related hypotension. Furthermore, the HR-QOL improvement effect were suggested. These results demonstrated the safety and effectiveness of ivabradine hydrochloride.

Keyphrases

heart rate
end stage renal disease
chronic kidney disease
randomized controlled trial
peritoneal dialysis
systematic review
ejection fraction
drug induced